1. Home
  2. RDY vs DTM Comparison

RDY vs DTM Comparison

Compare RDY & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • DTM
  • Stock Information
  • Founded
  • RDY 1984
  • DTM 2021
  • Country
  • RDY India
  • DTM United States
  • Employees
  • RDY N/A
  • DTM N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • DTM Oil & Gas Production
  • Sector
  • RDY Health Care
  • DTM Utilities
  • Exchange
  • RDY Nasdaq
  • DTM Nasdaq
  • Market Cap
  • RDY 11.6B
  • DTM 11.1B
  • IPO Year
  • RDY N/A
  • DTM N/A
  • Fundamental
  • Price
  • RDY $13.98
  • DTM $114.67
  • Analyst Decision
  • RDY Strong Buy
  • DTM Buy
  • Analyst Count
  • RDY 1
  • DTM 12
  • Target Price
  • RDY $16.90
  • DTM $118.08
  • AVG Volume (30 Days)
  • RDY 1.1M
  • DTM 796.6K
  • Earning Date
  • RDY 10-24-2025
  • DTM 10-30-2025
  • Dividend Yield
  • RDY 0.51%
  • DTM 2.86%
  • EPS Growth
  • RDY 9.95
  • DTM N/A
  • EPS
  • RDY 0.79
  • DTM 3.96
  • Revenue
  • RDY $3,851,623,984.00
  • DTM $1,175,000,000.00
  • Revenue This Year
  • RDY $6.29
  • DTM $27.01
  • Revenue Next Year
  • RDY $2.61
  • DTM $8.91
  • P/E Ratio
  • RDY $17.72
  • DTM $29.00
  • Revenue Growth
  • RDY 14.10
  • DTM 20.39
  • 52 Week Low
  • RDY $12.26
  • DTM $83.30
  • 52 Week High
  • RDY $16.17
  • DTM $117.12
  • Technical
  • Relative Strength Index (RSI)
  • RDY 51.87
  • DTM 59.10
  • Support Level
  • RDY $13.79
  • DTM $111.55
  • Resistance Level
  • RDY $14.02
  • DTM $115.58
  • Average True Range (ATR)
  • RDY 0.23
  • DTM 2.88
  • MACD
  • RDY 0.05
  • DTM 0.52
  • Stochastic Oscillator
  • RDY 93.92
  • DTM 79.08

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

Share on Social Networks: